Zhejiang Conba Pharmaceutical Co., Ltd. Class ASSE: 600572

"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Completion of Filing of Industrial and Commercial Registration Changes for the Transfer of 100% Equity Interest in Dongyang CONBA through Public Listing

Sep 1, 2026 · Issued by Zhejiang Conba Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Completion of Filing of Industrial and Commercial Registration Changes for the Transfer of 100% Equity Interest in Dongyang CONBA through Public Listing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Zhejiang Conba Pharmaceutical Co., Ltd. Class A

"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Key Operating Data for the First Half of 2026Aug 26
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Progress in Public Listing for Transfer of 100% Equity in Dongyang Kang'enbei Printing and Packaging Co., Ltd.Aug 18
"Zhejiang CONBA Pharmaceutical Co., Ltd."Indicative Announcement on the Restricted Exercise Period under the 2022 Stock Option Incentive PlanAug 5
"Zhejiang CONBA Pharmaceutical Co., Ltd."Announcement on Obtaining Notice of Approval for Drug Clinical Trial for New Indication of Shexiang Tongxin Dropping Pills by SubsidiaryJul 25

All Zhejiang Conba Pharmaceutical Co., Ltd. Class A news releases